News & Articles
Selected Filters:
Ortho Clinical Diagnostics’ quantitative COVID-19 IgG antibody test first to receive FDA EUA
VITROS Anti-SARS-CoV-2 IgG Quantitative Test targets the S1 spike protein and is calibrated to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies
Ortho Clinical Diagnostics has simultaneously launched first quantitative COVID-19 IgG spike antibody test and nucleocapsid antibody test
Both new antibody tests help healthcare teams differentiate the cause of antibodies against SARS-CoV-2
Ortho Clinical Diagnostics partners with Quest in the fight against coronavirus
Partnership to broaden the availability of COVID-19 antibody testing with 100% specificity
Ortho Clinical Diagnostics to share latest research and lab products for infectious disease and endocrinology at AACC 2019
Company will showcase its new and next-generation products, including Ortho’s VITROS® XT 7600 Integrated System
Ortho’s VITROS® High Sensitivity Troponin I Assay for the Diagnosis of Heart Attack Now CE Marked, Available in EU Countries
Next-generation assay aids in diagnosing heart attacks faster and more accurately, and is enabled on the company’s newest analyzer, the VITROS® XT 7600 Integrated System
Ortho Clinical Diagnostics Receives CE Mark for VITROS® XT 7600 Integrated System
Novel diagnostic technology enables powerful data intelligence, operational improvements and other enhancements in the lab
FDA Clears ORTHO VISION Max Analyzer for High-Volume Transfusion Medicine Labs
New Immunohematology System from Ortho Clinical Diagnostics Expands ORTHO VISION® Platform; Now Commercially Available in the United States
Ortho Clinical Diagnostics Announces Ortho Care
Best-in-class service and support program for hospitals, hospital networks, blood banks and labs